Your browser doesn't support javascript.
loading
GCM2 p.Tyr394Ser variant in Ashkenazi Israeli patients with suspected familial isolated hyperparathyroidism.
Szalat, Auryan; Shpitzen, Shoshana; Pollack, Rena; Mazeh, Haggi; Durst, Ronen; Meiner, Vardiella.
Affiliation
  • Szalat A; Endocrinology and Metabolism Service, Department of Internal Medicine, Osteoporosis Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Shpitzen S; Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Pollack R; Endocrinology and Metabolism Service, Department of Internal Medicine, Osteoporosis Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Mazeh H; Department of Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Durst R; Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Meiner V; Department of Genetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Front Endocrinol (Lausanne) ; 14: 1254156, 2023.
Article in En | MEDLINE | ID: mdl-38130397

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperparathyroidism, Primary Limits: Humans Country/Region as subject: Asia Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperparathyroidism, Primary Limits: Humans Country/Region as subject: Asia Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: Country of publication: